[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Olmesartan Medoxomil API Market, Global Outlook and Forecast 2022-2028

August 2022 | 114 pages | ID: O41D8B593C1DEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Olmesartan Medoxomil(CAS?144689-63-4) is a potent, orally active, selective angiotensin II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin II.

This report contains market size and forecasts of Olmesartan Medoxomil API in global, including the following market information:

Global Olmesartan Medoxomil API Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Olmesartan Medoxomil API Market Sales, 2017-2022, 2023-2028, (Kg)

Global top five Olmesartan Medoxomil API companies in 2021 (%)

The global Olmesartan Medoxomil API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 98 % Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Olmesartan Medoxomil API include Mylan, Arene Lifesciences Limited, Glenmark Pharmaceuticals, Hetero Drugs, Hikal, HONOUR LAB LTD, Interquim SA, Jai Radhe Sales and Jubilant Generics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Olmesartan Medoxomil API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Olmesartan Medoxomil API Market, by Purity, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Olmesartan Medoxomil API Market Segment Percentages, by Purity, 2021 (%)
  • Above 98 %
  • Above 99 %
Global Olmesartan Medoxomil API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Olmesartan Medoxomil API Market Segment Percentages, by Application, 2021 (%)
  • Tablets
  • Others
Global Olmesartan Medoxomil API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Olmesartan Medoxomil API Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Olmesartan Medoxomil API revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Olmesartan Medoxomil API revenues share in global market, 2021 (%)

Key companies Olmesartan Medoxomil API sales in global market, 2017-2022 (Estimated), (Kg)

Key companies Olmesartan Medoxomil API sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Mylan
  • Arene Lifesciences Limited
  • Glenmark Pharmaceuticals
  • Hetero Drugs
  • Hikal
  • HONOUR LAB LTD
  • Interquim SA
  • Jai Radhe Sales
  • Jubilant Generics
  • Morepen Laboratories
  • SGMR Pharmaceuticals
  • Tecoland Corporation
  • Teva
  • Zeon Health Industries
  • Zhuhai Rundu Pharmaceutical Co.,Ltd
  • Zydus Cadila
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Olmesartan Medoxomil API Market Definition
1.2 Market Segments
  1.2.1 Market by Purity
  1.2.2 Market by Application
1.3 Global Olmesartan Medoxomil API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OLMESARTAN MEDOXOMIL API OVERALL MARKET SIZE

2.1 Global Olmesartan Medoxomil API Market Size: 2021 VS 2028
2.2 Global Olmesartan Medoxomil API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Olmesartan Medoxomil API Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Olmesartan Medoxomil API Players in Global Market
3.2 Top Global Olmesartan Medoxomil API Companies Ranked by Revenue
3.3 Global Olmesartan Medoxomil API Revenue by Companies
3.4 Global Olmesartan Medoxomil API Sales by Companies
3.5 Global Olmesartan Medoxomil API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Olmesartan Medoxomil API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Olmesartan Medoxomil API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Olmesartan Medoxomil API Players in Global Market
  3.8.1 List of Global Tier 1 Olmesartan Medoxomil API Companies
  3.8.2 List of Global Tier 2 and Tier 3 Olmesartan Medoxomil API Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Purity - Global Olmesartan Medoxomil API Market Size Markets, 2021 & 2028
  4.1.2 Above 98 %
  4.1.3 Above 99 %
4.2 By Purity - Global Olmesartan Medoxomil API Revenue & Forecasts
  4.2.1 By Purity - Global Olmesartan Medoxomil API Revenue, 2017-2022
  4.2.2 By Purity - Global Olmesartan Medoxomil API Revenue, 2023-2028
  4.2.3 By Purity - Global Olmesartan Medoxomil API Revenue Market Share, 2017-2028
4.3 By Purity - Global Olmesartan Medoxomil API Sales & Forecasts
  4.3.1 By Purity - Global Olmesartan Medoxomil API Sales, 2017-2022
  4.3.2 By Purity - Global Olmesartan Medoxomil API Sales, 2023-2028
  4.3.3 By Purity - Global Olmesartan Medoxomil API Sales Market Share, 2017-2028
4.4 By Purity - Global Olmesartan Medoxomil API Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Olmesartan Medoxomil API Market Size, 2021 & 2028
  5.1.2 Tablets
  5.1.3 Others
5.2 By Application - Global Olmesartan Medoxomil API Revenue & Forecasts
  5.2.1 By Application - Global Olmesartan Medoxomil API Revenue, 2017-2022
  5.2.2 By Application - Global Olmesartan Medoxomil API Revenue, 2023-2028
  5.2.3 By Application - Global Olmesartan Medoxomil API Revenue Market Share, 2017-2028
5.3 By Application - Global Olmesartan Medoxomil API Sales & Forecasts
  5.3.1 By Application - Global Olmesartan Medoxomil API Sales, 2017-2022
  5.3.2 By Application - Global Olmesartan Medoxomil API Sales, 2023-2028
  5.3.3 By Application - Global Olmesartan Medoxomil API Sales Market Share, 2017-2028
5.4 By Application - Global Olmesartan Medoxomil API Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Olmesartan Medoxomil API Market Size, 2021 & 2028
6.2 By Region - Global Olmesartan Medoxomil API Revenue & Forecasts
  6.2.1 By Region - Global Olmesartan Medoxomil API Revenue, 2017-2022
  6.2.2 By Region - Global Olmesartan Medoxomil API Revenue, 2023-2028
  6.2.3 By Region - Global Olmesartan Medoxomil API Revenue Market Share, 2017-2028
6.3 By Region - Global Olmesartan Medoxomil API Sales & Forecasts
  6.3.1 By Region - Global Olmesartan Medoxomil API Sales, 2017-2022
  6.3.2 By Region - Global Olmesartan Medoxomil API Sales, 2023-2028
  6.3.3 By Region - Global Olmesartan Medoxomil API Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Olmesartan Medoxomil API Revenue, 2017-2028
  6.4.2 By Country - North America Olmesartan Medoxomil API Sales, 2017-2028
  6.4.3 US Olmesartan Medoxomil API Market Size, 2017-2028
  6.4.4 Canada Olmesartan Medoxomil API Market Size, 2017-2028
  6.4.5 Mexico Olmesartan Medoxomil API Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Olmesartan Medoxomil API Revenue, 2017-2028
  6.5.2 By Country - Europe Olmesartan Medoxomil API Sales, 2017-2028
  6.5.3 Germany Olmesartan Medoxomil API Market Size, 2017-2028
  6.5.4 France Olmesartan Medoxomil API Market Size, 2017-2028
  6.5.5 U.K. Olmesartan Medoxomil API Market Size, 2017-2028
  6.5.6 Italy Olmesartan Medoxomil API Market Size, 2017-2028
  6.5.7 Russia Olmesartan Medoxomil API Market Size, 2017-2028
  6.5.8 Nordic Countries Olmesartan Medoxomil API Market Size, 2017-2028
  6.5.9 Benelux Olmesartan Medoxomil API Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Olmesartan Medoxomil API Revenue, 2017-2028
  6.6.2 By Region - Asia Olmesartan Medoxomil API Sales, 2017-2028
  6.6.3 China Olmesartan Medoxomil API Market Size, 2017-2028
  6.6.4 Japan Olmesartan Medoxomil API Market Size, 2017-2028
  6.6.5 South Korea Olmesartan Medoxomil API Market Size, 2017-2028
  6.6.6 Southeast Asia Olmesartan Medoxomil API Market Size, 2017-2028
  6.6.7 India Olmesartan Medoxomil API Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Olmesartan Medoxomil API Revenue, 2017-2028
  6.7.2 By Country - South America Olmesartan Medoxomil API Sales, 2017-2028
  6.7.3 Brazil Olmesartan Medoxomil API Market Size, 2017-2028
  6.7.4 Argentina Olmesartan Medoxomil API Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Olmesartan Medoxomil API Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Olmesartan Medoxomil API Sales, 2017-2028
  6.8.3 Turkey Olmesartan Medoxomil API Market Size, 2017-2028
  6.8.4 Israel Olmesartan Medoxomil API Market Size, 2017-2028
  6.8.5 Saudi Arabia Olmesartan Medoxomil API Market Size, 2017-2028
  6.8.6 UAE Olmesartan Medoxomil API Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Mylan
  7.1.1 Mylan Corporate Summary
  7.1.2 Mylan Business Overview
  7.1.3 Mylan Olmesartan Medoxomil API Major Product Offerings
  7.1.4 Mylan Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.1.5 Mylan Key News
7.2 Arene Lifesciences Limited
  7.2.1 Arene Lifesciences Limited Corporate Summary
  7.2.2 Arene Lifesciences Limited Business Overview
  7.2.3 Arene Lifesciences Limited Olmesartan Medoxomil API Major Product Offerings
  7.2.4 Arene Lifesciences Limited Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.2.5 Arene Lifesciences Limited Key News
7.3 Glenmark Pharmaceuticals
  7.3.1 Glenmark Pharmaceuticals Corporate Summary
  7.3.2 Glenmark Pharmaceuticals Business Overview
  7.3.3 Glenmark Pharmaceuticals Olmesartan Medoxomil API Major Product Offerings
  7.3.4 Glenmark Pharmaceuticals Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.3.5 Glenmark Pharmaceuticals Key News
7.4 Hetero Drugs
  7.4.1 Hetero Drugs Corporate Summary
  7.4.2 Hetero Drugs Business Overview
  7.4.3 Hetero Drugs Olmesartan Medoxomil API Major Product Offerings
  7.4.4 Hetero Drugs Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.4.5 Hetero Drugs Key News
7.5 Hikal
  7.5.1 Hikal Corporate Summary
  7.5.2 Hikal Business Overview
  7.5.3 Hikal Olmesartan Medoxomil API Major Product Offerings
  7.5.4 Hikal Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.5.5 Hikal Key News
7.6 HONOUR LAB LTD
  7.6.1 HONOUR LAB LTD Corporate Summary
  7.6.2 HONOUR LAB LTD Business Overview
  7.6.3 HONOUR LAB LTD Olmesartan Medoxomil API Major Product Offerings
  7.6.4 HONOUR LAB LTD Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.6.5 HONOUR LAB LTD Key News
7.7 Interquim SA
  7.7.1 Interquim SA Corporate Summary
  7.7.2 Interquim SA Business Overview
  7.7.3 Interquim SA Olmesartan Medoxomil API Major Product Offerings
  7.7.4 Interquim SA Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.7.5 Interquim SA Key News
7.8 Jai Radhe Sales
  7.8.1 Jai Radhe Sales Corporate Summary
  7.8.2 Jai Radhe Sales Business Overview
  7.8.3 Jai Radhe Sales Olmesartan Medoxomil API Major Product Offerings
  7.8.4 Jai Radhe Sales Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.8.5 Jai Radhe Sales Key News
7.9 Jubilant Generics
  7.9.1 Jubilant Generics Corporate Summary
  7.9.2 Jubilant Generics Business Overview
  7.9.3 Jubilant Generics Olmesartan Medoxomil API Major Product Offerings
  7.9.4 Jubilant Generics Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.9.5 Jubilant Generics Key News
7.10 Morepen Laboratories
  7.10.1 Morepen Laboratories Corporate Summary
  7.10.2 Morepen Laboratories Business Overview
  7.10.3 Morepen Laboratories Olmesartan Medoxomil API Major Product Offerings
  7.10.4 Morepen Laboratories Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.10.5 Morepen Laboratories Key News
7.11 SGMR Pharmaceuticals
  7.11.1 SGMR Pharmaceuticals Corporate Summary
  7.11.2 SGMR Pharmaceuticals Olmesartan Medoxomil API Business Overview
  7.11.3 SGMR Pharmaceuticals Olmesartan Medoxomil API Major Product Offerings
  7.11.4 SGMR Pharmaceuticals Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.11.5 SGMR Pharmaceuticals Key News
7.12 Tecoland Corporation
  7.12.1 Tecoland Corporation Corporate Summary
  7.12.2 Tecoland Corporation Olmesartan Medoxomil API Business Overview
  7.12.3 Tecoland Corporation Olmesartan Medoxomil API Major Product Offerings
  7.12.4 Tecoland Corporation Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.12.5 Tecoland Corporation Key News
7.13 Teva
  7.13.1 Teva Corporate Summary
  7.13.2 Teva Olmesartan Medoxomil API Business Overview
  7.13.3 Teva Olmesartan Medoxomil API Major Product Offerings
  7.13.4 Teva Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.13.5 Teva Key News
7.14 Zeon Health Industries
  7.14.1 Zeon Health Industries Corporate Summary
  7.14.2 Zeon Health Industries Business Overview
  7.14.3 Zeon Health Industries Olmesartan Medoxomil API Major Product Offerings
  7.14.4 Zeon Health Industries Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.14.5 Zeon Health Industries Key News
7.15 Zhuhai Rundu Pharmaceutical Co.,Ltd
  7.15.1 Zhuhai Rundu Pharmaceutical Co.,Ltd Corporate Summary
  7.15.2 Zhuhai Rundu Pharmaceutical Co.,Ltd Business Overview
  7.15.3 Zhuhai Rundu Pharmaceutical Co.,Ltd Olmesartan Medoxomil API Major Product Offerings
  7.15.4 Zhuhai Rundu Pharmaceutical Co.,Ltd Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.15.5 Zhuhai Rundu Pharmaceutical Co.,Ltd Key News
7.16 Zydus Cadila
  7.16.1 Zydus Cadila Corporate Summary
  7.16.2 Zydus Cadila Business Overview
  7.16.3 Zydus Cadila Olmesartan Medoxomil API Major Product Offerings
  7.16.4 Zydus Cadila Olmesartan Medoxomil API Sales and Revenue in Global (2017-2022)
  7.16.5 Zydus Cadila Key News

8 GLOBAL OLMESARTAN MEDOXOMIL API PRODUCTION CAPACITY, ANALYSIS

8.1 Global Olmesartan Medoxomil API Production Capacity, 2017-2028
8.2 Olmesartan Medoxomil API Production Capacity of Key Manufacturers in Global Market
8.3 Global Olmesartan Medoxomil API Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 OLMESARTAN MEDOXOMIL API SUPPLY CHAIN ANALYSIS

10.1 Olmesartan Medoxomil API Industry Value Chain
10.2 Olmesartan Medoxomil API Upstream Market
10.3 Olmesartan Medoxomil API Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Olmesartan Medoxomil API Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Olmesartan Medoxomil API in Global Market
Table 2. Top Olmesartan Medoxomil API Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Olmesartan Medoxomil API Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Olmesartan Medoxomil API Revenue Share by Companies, 2017-2022
Table 5. Global Olmesartan Medoxomil API Sales by Companies, (Kg), 2017-2022
Table 6. Global Olmesartan Medoxomil API Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Olmesartan Medoxomil API Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Olmesartan Medoxomil API Product Type
Table 9. List of Global Tier 1 Olmesartan Medoxomil API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Olmesartan Medoxomil API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Purity – Global Olmesartan Medoxomil API Revenue, (US$, Mn), 2021 & 2028
Table 12. By Purity - Global Olmesartan Medoxomil API Revenue (US$, Mn), 2017-2022
Table 13. By Purity - Global Olmesartan Medoxomil API Revenue (US$, Mn), 2023-2028
Table 14. By Purity - Global Olmesartan Medoxomil API Sales (Kg), 2017-2022
Table 15. By Purity - Global Olmesartan Medoxomil API Sales (Kg), 2023-2028
Table 16. By Application – Global Olmesartan Medoxomil API Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Olmesartan Medoxomil API Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Olmesartan Medoxomil API Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Olmesartan Medoxomil API Sales (Kg), 2017-2022
Table 20. By Application - Global Olmesartan Medoxomil API Sales (Kg), 2023-2028
Table 21. By Region – Global Olmesartan Medoxomil API Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Olmesartan Medoxomil API Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Olmesartan Medoxomil API Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Olmesartan Medoxomil API Sales (Kg), 2017-2022
Table 25. By Region - Global Olmesartan Medoxomil API Sales (Kg), 2023-2028
Table 26. By Country - North America Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Olmesartan Medoxomil API Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Olmesartan Medoxomil API Sales, (Kg), 2017-2022
Table 29. By Country - North America Olmesartan Medoxomil API Sales, (Kg), 2023-2028
Table 30. By Country - Europe Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Olmesartan Medoxomil API Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Olmesartan Medoxomil API Sales, (Kg), 2017-2022
Table 33. By Country - Europe Olmesartan Medoxomil API Sales, (Kg), 2023-2028
Table 34. By Region - Asia Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Olmesartan Medoxomil API Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Olmesartan Medoxomil API Sales, (Kg), 2017-2022
Table 37. By Region - Asia Olmesartan Medoxomil API Sales, (Kg), 2023-2028
Table 38. By Country - South America Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Olmesartan Medoxomil API Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Olmesartan Medoxomil API Sales, (Kg), 2017-2022
Table 41. By Country - South America Olmesartan Medoxomil API Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Olmesartan Medoxomil API Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Olmesartan Medoxomil API Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Olmesartan Medoxomil API Sales, (Kg), 2023-2028
Table 46. Mylan Corporate Summary
Table 47. Mylan Olmesartan Medoxomil API Product Offerings
Table 48. Mylan Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. Arene Lifesciences Limited Corporate Summary
Table 50. Arene Lifesciences Limited Olmesartan Medoxomil API Product Offerings
Table 51. Arene Lifesciences Limited Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Glenmark Pharmaceuticals Corporate Summary
Table 53. Glenmark Pharmaceuticals Olmesartan Medoxomil API Product Offerings
Table 54. Glenmark Pharmaceuticals Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Hetero Drugs Corporate Summary
Table 56. Hetero Drugs Olmesartan Medoxomil API Product Offerings
Table 57. Hetero Drugs Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Hikal Corporate Summary
Table 59. Hikal Olmesartan Medoxomil API Product Offerings
Table 60. Hikal Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. HONOUR LAB LTD Corporate Summary
Table 62. HONOUR LAB LTD Olmesartan Medoxomil API Product Offerings
Table 63. HONOUR LAB LTD Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Interquim SA Corporate Summary
Table 65. Interquim SA Olmesartan Medoxomil API Product Offerings
Table 66. Interquim SA Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Jai Radhe Sales Corporate Summary
Table 68. Jai Radhe Sales Olmesartan Medoxomil API Product Offerings
Table 69. Jai Radhe Sales Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Jubilant Generics Corporate Summary
Table 71. Jubilant Generics Olmesartan Medoxomil API Product Offerings
Table 72. Jubilant Generics Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Morepen Laboratories Corporate Summary
Table 74. Morepen Laboratories Olmesartan Medoxomil API Product Offerings
Table 75. Morepen Laboratories Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. SGMR Pharmaceuticals Corporate Summary
Table 77. SGMR Pharmaceuticals Olmesartan Medoxomil API Product Offerings
Table 78. SGMR Pharmaceuticals Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Tecoland Corporation Corporate Summary
Table 80. Tecoland Corporation Olmesartan Medoxomil API Product Offerings
Table 81. Tecoland Corporation Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Teva Corporate Summary
Table 83. Teva Olmesartan Medoxomil API Product Offerings
Table 84. Teva Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Zeon Health Industries Corporate Summary
Table 86. Zeon Health Industries Olmesartan Medoxomil API Product Offerings
Table 87. Zeon Health Industries Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 88. Zhuhai Rundu Pharmaceutical Co.,Ltd Corporate Summary
Table 89. Zhuhai Rundu Pharmaceutical Co.,Ltd Olmesartan Medoxomil API Product Offerings
Table 90. Zhuhai Rundu Pharmaceutical Co.,Ltd Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 91. Zydus Cadila Corporate Summary
Table 92. Zydus Cadila Olmesartan Medoxomil API Product Offerings
Table 93. Zydus Cadila Olmesartan Medoxomil API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 94. Olmesartan Medoxomil API Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 95. Global Olmesartan Medoxomil API Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Olmesartan Medoxomil API Production by Region, 2017-2022 (Kg)
Table 97. Global Olmesartan Medoxomil API Production by Region, 2023-2028 (Kg)
Table 98. Olmesartan Medoxomil API Market Opportunities & Trends in Global Market
Table 99. Olmesartan Medoxomil API Market Drivers in Global Market
Table 100. Olmesartan Medoxomil API Market Restraints in Global Market
Table 101. Olmesartan Medoxomil API Raw Materials
Table 102. Olmesartan Medoxomil API Raw Materials Suppliers in Global Market
Table 103. Typical Olmesartan Medoxomil API Downstream
Table 104. Olmesartan Medoxomil API Downstream Clients in Global Market
Table 105. Olmesartan Medoxomil API Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Olmesartan Medoxomil API Segment by Purity
Figure 2. Olmesartan Medoxomil API Segment by Application
Figure 3. Global Olmesartan Medoxomil API Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Olmesartan Medoxomil API Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Olmesartan Medoxomil API Revenue, 2017-2028 (US$, Mn)
Figure 7. Olmesartan Medoxomil API Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Olmesartan Medoxomil API Revenue in 2021
Figure 9. By Purity - Global Olmesartan Medoxomil API Sales Market Share, 2017-2028
Figure 10. By Purity - Global Olmesartan Medoxomil API Revenue Market Share, 2017-2028
Figure 11. By Purity - Global Olmesartan Medoxomil API Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Olmesartan Medoxomil API Sales Market Share, 2017-2028
Figure 13. By Application - Global Olmesartan Medoxomil API Revenue Market Share, 2017-2028
Figure 14. By Application - Global Olmesartan Medoxomil API Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Olmesartan Medoxomil API Sales Market Share, 2017-2028
Figure 16. By Region - Global Olmesartan Medoxomil API Revenue Market Share, 2017-2028
Figure 17. By Country - North America Olmesartan Medoxomil API Revenue Market Share, 2017-2028
Figure 18. By Country - North America Olmesartan Medoxomil API Sales Market Share, 2017-2028
Figure 19. US Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Olmesartan Medoxomil API Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Olmesartan Medoxomil API Sales Market Share, 2017-2028
Figure 24. Germany Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 25. France Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Olmesartan Medoxomil API Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Olmesartan Medoxomil API Sales Market Share, 2017-2028
Figure 33. China Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 37. India Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Olmesartan Medoxomil API Revenue Market Share, 2017-2028
Figure 39. By Country - South America Olmesartan Medoxomil API Sales Market Share, 2017-2028
Figure 40. Brazil Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Olmesartan Medoxomil API Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Olmesartan Medoxomil API Sales Market Share, 2017-2028
Figure 44. Turkey Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Olmesartan Medoxomil API Revenue, (US$, Mn), 2017-2028
Figure 48. Global Olmesartan Medoxomil API Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Olmesartan Medoxomil API by Region, 2021 VS 2028
Figure 50. Olmesartan Medoxomil API Industry Value Chain
Figure 51. Marketing Channels


More Publications